BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND ABL2, ARG, 27, ENSG00000143322, P42684, ABLL, RP11-177A2_3 AND Treatment
21968 results:

  • 1. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
    Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
    Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
    Lin AL; Rudneva VA; Richards AL; Zhang Y; Woo HJ; Cohen M; Tisnado J; Majd N; Wardlaw SL; Page-Wilson G; Sengupta S; Chow F; Goichot B; Ozer BH; Dietrich J; Nachtigall L; Desai A; Alano T; Ogilive S; Solit DB; Bale TA; Rosenblum M; Donoghue MTA; Geer EB; Tabar V
    Acta Neuropathol; 2024 May; 147(1):85. PubMed ID: 38758238
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
    Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
    Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Preoperative walking exercise to improve prognosis in patients with supratentorial brain tumours after craniotomy: protocol for a randomised controlled trial.
    Qu C; Cao Z; Zhou J; He S; Liu F; Liu Z
    BMJ Open; 2024 May; 14(5):e080787. PubMed ID: 38754891
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study.
    Zheng Y; Chen Z; Song W; Xu Y; Zhao Z; Sun Y; Wang Y; Geng X; Zhao J; Zhang X; Xu Y; Chan JSK; Tse G; Li G; Hong L; Liu T
    Cancer Med; 2024 May; 13(10):e7233. PubMed ID: 38752474
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. METTL8 links mt-tRNA m
    Lee BWL; Chuah YH; Yoon J; Grinchuk OV; Liang Y; Hirpara JL; Shen Y; Wang LC; Lim YT; Zhao T; Sobota RM; Yeo TT; Wong ALA; Teo K; Nga VDW; Tan BWQ; Suda T; Toh TB; Pervaiz S; Lin Z; Ong DST
    Cell Death Dis; 2024 May; 15(5):338. PubMed ID: 38744809
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Zavegepant for Acute treatment of Migraine: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Suresh V; Bardhan M; Dave T; Shamim MA; Suresh D; Satish P; Dhakal B; Bhonsale A; Roy P; Padhi BK; Monteith T
    Clin Neuropharmacol; 2024 May-Jun 01; 47(3):72-81. PubMed ID: 38743600
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
    da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
    Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France.
    Petit T; Hajjaji N; Antoine EC; Benderra MA; Gozy M; Foa C; Mouysset JL; Grenier J; Mousseau M; Mailliez A; Saghatchian M; Lachaier E; Desmoulins I; Hennequin A; Maes P; Loirat D; Ricci F; Diéras V; Berton D; Tiong FL; Teixeira L; Dohollou N; Lévy C; Bachelot T; Pierga JY
    Cancer Med; 2024 May; 13(9):e7168. PubMed ID: 38733172
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Management of Autoimmune Encephalitis in a 7-Year-Old Child With CTLA-4 Haploinsufficiency and AMPA Receptor Antibodies: A Case Report.
    Quaak MSW; Buijze MSJS; Verhoeven VJM; Vermont C; Buddingh EP; Heredia M; Samsom JN; Titulaer MJ; van Rossum AM; Kamphuis S; Neuteboom RF
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200254. PubMed ID: 38728609
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting Integrin α3 Blocks β1 Maturation, Triggers Endoplasmic Reticulum Stress, and Sensitizes Glioblastoma Cells to TRAIL-Mediated Apoptosis.
    Kuranaga Y; Yu B; Osuka S; Zhang H; Devi NS; Bae S; Van Meir EG
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727288
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Vaccimel immunization is associated with enhanced response to treatment with anti-PD-1 monoclonal antibodies in cutaneous melanoma patients - a case reports study.
    Mordoh J; Schwab E; Bravo AI; Aris M; Barrio MM
    Front Immunol; 2024; 15():1354710. PubMed ID: 38726010
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Glioblastoma: a comprehensive approach combining bibliometric analysis, Latent Dirichlet Allocation, and HJ-Biplot : Glioblastoma insights and trends: a 49-year bibliometric analysis.
    Montes-Escobar K; de la Hoz-M J; Castillo-Cordova P; Duran-Ospina JP; Bravo-Saltos RK; Lapo-Talledo GJ; Siteneski A
    Neurosurg Rev; 2024 May; 47(1):209. PubMed ID: 38724684
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Glioma.
    Weller M; Wen PY; Chang SM; Dirven L; Lim M; Monje M; Reifenberger G
    Nat Rev Dis Primers; 2024 May; 10(1):33. PubMed ID: 38724526
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Simultaneous targeting of peripheral and brain tumors with a therapeutic nanoparticle to disrupt metabolic adaptability at both sites.
    Ashokan A; Sarkar S; Kamran MZ; Surnar B; Kalathil AA; Spencer A; Dhar S
    Proc Natl Acad Sci U S A; 2024 May; 121(20):e2318119121. PubMed ID: 38709930
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Efficacy of ferric carboxymaltose on haemoglobin response among older patients with gastrointestinal bleeding: a randomised clinical trial.
    Richard N; Arab-Hocine N; Vannier M; Leblanc-Boubchir R; Pelaquier A; Boruchowicz A; Musikas M; Amil M; Fumery M; Nahon S; Arotcarena R; Gelsi E; Maurin A; Hébuterne X; Savoye G
    Age Ageing; 2024 May; 53(5):. PubMed ID: 38706390
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Early therapy evaluation of intra-arterial trastuzumab injection in a human breast cancer xenograft model using multiparametric MR imaging.
    Kim BK; Kim B; You SH; Jang MS; Im GH; Kim KH
    PLoS One; 2024; 19(5):e0300171. PubMed ID: 38701062
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pituitary abscess: a descriptive analysis of a series of 19 patients-a multi-center experience.
    Xue Q; Shi X; Fu X; Yin Y; Zhou H; Liu S; Sun Q; Meng J; Bian L; Tan H; He H
    Eur J Med Res; 2024 May; 29(1):262. PubMed ID: 38698484
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Investigation of high-dose radiotherapy's effect on brain structure aggravated cognitive impairment and deteriorated patient psychological status in brain tumor treatment.
    Ma J; Cao H; Hou D; Wang W; Liu T
    Sci Rep; 2024 May; 14(1):10149. PubMed ID: 38698048
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Response of treatment-naive brain metastases to stereotactic radiosurgery.
    Ene CI; Abi Faraj C; Beckham TH; Weinberg JS; Andersen CR; Haider AS; Rao G; Ferguson SD; Alvarez-Brenkenridge CA; Kim BYS; Heimberger AB; McCutcheon IE; Prabhu SS; Wang CM; Ghia AJ; McGovern SL; Chung C; McAleer MF; Tom MC; Perni S; Swanson TA; Yeboa DN; Briere TM; Huse JT; Fuller GN; Lang FF; Li J; Suki D; Sawaya RE
    Nat Commun; 2024 May; 15(1):3728. PubMed ID: 38697991
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1099.